VAL-0417

N/A

Report date: 2025/01/26 15:18:21

Base Information

Drug NameVAL-0417
Drug Alias Name4s3-005VAL-0417
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment +[5] 
Mechanisms of ActionEnzymes stimulants
TargetsEnzymes
Therapy Area/IndicationsGlycogen Storage Disease Type IIILafora Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesValerion Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesValerion Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type IIILafora Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A